These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1399682)

  • 21. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA
    Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBF.
    van Dyck CH; Seibyl JP; Stubbs JB; Zoghbi S; Wisniewski G; Baldwin RM; Zea-Ponce Y; Charney DS; Hoffer PB; Innis RB
    Nucl Med Biol; 1996 Jan; 23(1):9-16. PubMed ID: 9004921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of radioiodinated butyrophenones as radiotracer for dopamine receptor study.
    Nakatsuka I; Saji H; Shiba K; Shimizu H; Okuno M; Yoshitake A; Yokoyama A
    Life Sci; 1987 Oct; 41(17):1989-97. PubMed ID: 2959832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological evaluation of (+)-2- [123I]A-69024: a radioligand for in vivo studies of dopamine D1 receptors.
    Kassiou M; Mardon K; Mattner F; Katsifis A; Dikic B
    Life Sci; 2001 Jun; 69(6):669-75. PubMed ID: 11476188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Brain SPECT with 123I-lisuride in patients with Parkinson's disease and controls].
    Hierholzer J; Cordes M; Schelosky L; Richter W; Schrag A; Poewe W; Schulze PE; Semmler W; Eichstädt H; Felix R
    Nuklearmedizin; 1995 Aug; 34(4):141-5. PubMed ID: 7675643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
    de Herder WW; Reijs AE; de Swart J; Kaandorp Y; Lamberts SW; Krenning EP; Kwekkeboom DJ
    Eur J Nucl Med; 1999 Jan; 26(1):46-50. PubMed ID: 9933661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo studies of [125I]iodobenzamide and [11C]iodobenzamide: a ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D2 dopamine receptors.
    Wong DF; Wilson AA; Chen C; Minkin E; Dannals RF; Ravert HT; Sanchez-Roa P; Villemagne V; Wagner HN
    Synapse; 1992 Nov; 12(3):236-41. PubMed ID: 1481143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2-receptor density in humans as assessed with SPET and the new high-affinity ligand 123I-NCQ298: a pilot study.
    Ryding E; Tuninger E; Ohlsson T; Sjöholm H; Freccero-Rosman K; Levander S; Rosén I
    Nucl Med Commun; 1998 Mar; 19(3):263-70. PubMed ID: 9625502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.
    Baldwin RM; Zea-Ponce Y; Zoghbi SS; Laurelle M; al-Tikriti MS; Sybirska EH; Malison RT; Neumeyer JL; Milius RA; Wang S
    Nucl Med Biol; 1993 Jul; 20(5):597-606. PubMed ID: 8358345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA; Kuikka JT; Ahonen A; Vanninen E
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating Dopamine D2 receptor with SPECT (II); pharmacokinetics study and quantification in the brain].
    Yonekura Y; Sadato N; Tsuchida T; Uematsu H; Nakamura S; Onishi Y; Yamamoto K; Ishii Y
    Kaku Igaku; 1999 Feb; 36(2):155-68. PubMed ID: 10213983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.
    Laruelle M; van Dyck C; Abi-Dargham A; Zea-Ponce Y; Zoghbi SS; Charney DS; Baldwin RM; Hoffer PB; Kung HF; Innis RB
    J Nucl Med; 1994 May; 35(5):743-54. PubMed ID: 8176454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
    Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
    Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
    Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
    Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiobrominated spiroperidol for the study of dopamine D2 receptors.
    De Jesus OT; Friedman AM
    Int J Rad Appl Instrum A; 1986; 37(8):719-26. PubMed ID: 3021673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonist.
    Zea-Ponce Y; Kegeles LS; Guo N; Raskin L; Bakthavachalam V; Laruelle M
    Nucl Med Biol; 2002 Jul; 29(5):575-83. PubMed ID: 12088728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiochemical synthesis of [123I]2-iodo-lisuride for dopamine D2-receptor studies.
    Bier D; Dutschka K; Knust EJ
    Nucl Med Biol; 1996 Apr; 23(3):373-6. PubMed ID: 8782250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?
    Verhoeff NP; Visser WH; Ferrari MD; Saxena PR; van Royen EA
    Cephalalgia; 1993 Oct; 13(5):325-9. PubMed ID: 8242725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.